Research output per year
Research output per year
Fingerprint
Dive into the research topics where Daniela Sartori is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 5 Article
-
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial: European Journal of Cancer
Caffo, O., Ortega, C., Nolè, F., Gasparro, D., Mucciarini, C., Aieta, M., Zagonel, V., Iacovelli, R., De Giorgi, U., Facchini, G., Veccia, A., Palesandro, E., Verri, E., Buti, S., Razzini, G., Bozza, G., Maruzzo, M., Ciccarese, C., Schepisi, G., Rossetti, S., & 20 others, 2021, In: Eur. J. Cancer. 155, p. 56-63 8 p.Research output: Contribution to journal › Article › peer-review
-
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies
Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L., & 31 others, 2020, In: Breast Care. 15, 1, p. 30-37 8 p.Research output: Contribution to journal › Article › peer-review
-
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG: Therapeutic Advances in Medical Oncology
Federation of Italian Cooperative Oncology Groups (FICOG), 2020, In: Ther. Adv. Med. Oncol.. 12, 12 p.Research output: Contribution to journal › Article › peer-review
-
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
Bersanelli, M., Giannarelli, D., De Giorgi, U., Pignata, S., Di Maio, M., Verzoni, E., Clemente, A., Guadalupi, V., Signorelli, D., Tiseo, M., Giusti, R., Filetti, M., Di Napoli, M., Calvetti, L., Cappetta, A., Ermacora, P., Zara, D., Barbieri, F., Baldessari, C., Scotti, V., & 53 others, 2020, In: Therapeutic Advances in Medical Oncology. 12, 1758835920968463.Research output: Contribution to journal › Article › peer-review
-
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
Bersanelli, M., Giannarelli, D., De Giorgi, U., Pignata, S., Di Maio, M., Verzoni, E., Clemente, A., Guadalupi, V., Signorelli, D., Tiseo, M., Giusti, R., Filetti, M., Di Napoli, M., Calvetti, L., Cappetta, A., Ermacora, P., Zara, D., Barbieri, F., Baldessari, C., Scotti, V., & 53 others, 2020, In: Therapeutic Advances in Medical Oncology. 12Research output: Contribution to journal › Article › peer-review